Clinical outcomes and Guardant360 circulating tumor DNA profiling in ALK-positive non-small cell lung cancer treated with lorlatinib after alectinib

JAAD International · Elsevier

Аннотация

Publication date: Available online 24 October 2026 Source: International Journal of Lung Cancer Author(s): Yasushi Goto, Tadaaki Yamada, Akehiro Nishiyama, Naoko Aragane, Minehiko Inomata, Hiroki Nagai, Satoshi Takahashi, Kazuhito Miyazaki, Yukari Tsubata, Hiroaki Akamatsu, Tetsuya Mitsudomi

Читать у издателя →

Похожие статьи